Approaches to prevent dopamine quinone-induced neurotoxicity (Q37260391)

19 August 2017

1 reference

title

Approaches to prevent dopamine quinone-induced neurotoxicity (English)

1 reference

19 August 2017

0 references

1 reference

Ikuko Miyazaki

1

1 reference

19 August 2017

Masato Asanuma

series ordinal

2

1 reference

19 August 2017

publication date

4 September 2008

1 reference

19 August 2017

published in

Neurochemical Research

1 reference

19 August 2017

volume

34

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

698-706

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-008-9843-1

19 August 2017

exact match

0 references

cites work

Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-008-9843-1

Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-008-9843-1

Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules

21 January 2018

1 reference

12 December 2020

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

12 December 2020

Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

1 reference

12 December 2020

Dopamine induces proteasome inhibition in neural PC12 cell line.

1 reference

12 December 2020

Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice

1 reference

12 December 2020

L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells

1 reference

12 December 2020

Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism

1 reference

12 December 2020

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

1 reference

12 December 2020

Metallothioneins are multipurpose neuroprotectants during brain pathology

1 reference

12 December 2020

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

1 reference

12 December 2020

Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis

1 reference

12 December 2020

Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease

1 reference

12 December 2020

Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

1 reference

12 December 2020

Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical.

1 reference

12 December 2020

Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease

1 reference

12 December 2020

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

12 December 2020

Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease.

1 reference

12 December 2020

Catecholamines oxidation by xanthine oxidase

1 reference

12 December 2020

Metallothionein (MT) isoforms in the central nervous system (CNS): regional and cell-specific distribution and potential functions as an antioxidant

1 reference

12 December 2020

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

1 reference

12 December 2020

Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats

1 reference

12 December 2020

Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation.

1 reference

12 December 2020

Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.

1 reference

12 December 2020

Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.

1 reference

12 December 2020

Role of metallothionein and other antioxidants in scavenging superoxide radicals and their possible role in neuroprotection.

1 reference

12 December 2020

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

1 reference

12 December 2020

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin

1 reference

12 December 2020

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.

1 reference

12 December 2020

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

1 reference

12 December 2020

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

1 reference

12 December 2020

Metallothionein, neurotrophins and selegiline in providing neuroprotection in Parkinson's disease.

1 reference

12 December 2020

Effect of superoxide dismutase on the autoxidation of various hydroquinones--a possible role of superoxide dismutase as a superoxide:semiquinone oxidoreductase

1 reference

12 December 2020

Dopamine covalently modifies and functionally inactivates parkin

1 reference

12 December 2020

CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

1 reference

12 December 2020

Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro

1 reference

12 December 2020

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.

1 reference

12 December 2020

Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes

1 reference

12 December 2020

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Oxygen free radicals and metallothionein

1 reference

12 December 2020

Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases

1 reference

12 December 2020

Lipoxygenase-Catalyzed Oxidation of Catecholamines

1 reference

12 December 2020

Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage.

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage

1 reference

12 December 2020

Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity

1 reference

12 December 2020

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

1 reference

12 December 2020

Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.

1 reference

12 December 2020

A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition

1 reference

12 December 2020

Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death

1 reference

12 December 2020

Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro

1 reference

12 December 2020

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

1 reference

12 December 2020

Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry

1 reference

12 December 2020

Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.

1 reference

12 December 2020

Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice.

1 reference

12 December 2020

Increased dopamine and its metabolites in SH‐SY5Y neuroblastoma cells that express tyrosinase

1 reference

12 December 2020

Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine

1 reference

12 December 2020

Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons

1 reference

12 December 2020

Overexpression of Cu-Zn superoxide dismutase protects neuroblastoma cells against dopamine cytotoxicity accompanied by increase in their glutathione level

1 reference

12 December 2020

Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

1 reference

12 December 2020

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

1 reference

12 December 2020

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Free radicals and the pathobiology of brain dopamine systems

1 reference

12 December 2020

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

12 December 2020

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

1 reference

12 December 2020

Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells

1 reference

12 December 2020

Potential oxidative pathways of brain catecholamines

1 reference

12 December 2020

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

1 reference

12 December 2020

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation

1 reference

12 December 2020

Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease

1 reference

12 December 2020

Glial dysfunction in parkin null mice: effects of aging.

1 reference

12 December 2020

Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

1 reference

12 December 2020

Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors

1 reference

12 December 2020

Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum

1 reference

12 December 2020

Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug

1 reference

12 December 2020

15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors

1 reference

12 December 2020

Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells

1 reference

12 December 2020

The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals

1 reference

12 December 2020

Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

12 December 2020

Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist

1 reference

12 December 2020

Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers

1 reference

12 December 2020

Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration.

1 reference

12 December 2020

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.

1 reference

12 December 2020

Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.

1 reference

12 December 2020

Antioxidant activity of metallothionein compared with reduced glutathione

1 reference

12 December 2020

10.1007/S11064-008-9843-1

Identifiers

DOI

1 reference

19 August 2017

1 reference